Your browser doesn't support javascript.
loading
Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats.
Jingrui, Zheng; Weijian, Chen; Binbin, Y E; Ziyao, M O; Qunqun, D U; Renan, Qin; Ke, Nie.
Afiliación
  • Jingrui Z; School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Weijian C; School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Binbin YE; School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Ziyao MO; School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Qunqun DU; Modern Chinese Medicine Research Institute, Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd., Guangzhou 510228, China.
  • Renan Q; Modern Chinese Medicine Research Institute, Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd., Guangzhou 510228, China.
  • Ke N; School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
J Tradit Chin Med ; 44(4): 694-702, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39066530
ABSTRACT

OBJECTIVE:

To determine the therapeutic effects of the Zhuangyao Jianshen pill (, ZYJSP) against benign prostatic hyperplasia (BPH) and investigate the underlying mechanism.

METHODS:

Forty-eight male Sprague-Dawley rats were randomly divided into six groups Control group, BPH model group, finasteride-treated group, ZYJSP low, medium and high dose groups. Except for the control group, 40 rats were castrated and injected with testosterone propionate (TP) for 28 consecutive day to induce BPH. Meanwhile, the corresponding drugs were administered by gavage. The prostate wet weight, prostate index (PI), and the histopathological changes in the prostate were measured as the basis for examining the efficacy of ZYJSP against BPH. Levels of the serum sex hormones, oxidative stress markers, inflammatory markers, renal function markers, growth factors, and Cyclin D1 expression in prostate were measured to characterize the therapeutic mechanism of ZYJSP against BPH.

RESULTS:

ZYJSP administration significantly reduced prostate wet weight and PI and ameliorated histological changes of the prostate in TP-treated castrated rats. TP markedly increased the levels of creatinine, blood urea nitrogen and growth factors in the serum as well as the expression of the Cyclin D1 in the prostate. Most of these markers were significantly decreased by ZYJSP. ZYJSP significantly restored the dysregulation of testosterone, estradiol, and dihydrotestosterone caused by TP. Furthermore, ZYJSP relieved TP-induced prostate injury and exhibited both anti-inflammatory and anti-oxidant activity by decreasing interleukin-6, interleukin-8, and malondialdehyde levels and increasing the activity of superoxide dismutase in the serum.

CONCLUSION:

These findings indicate that ZYJSP can effectively ameliorate BPH induced by TP in castrated rats, and the underlying mechanism might be related to regulating sex hormone balance, reducing oxidative stress, and inhibiting the inflammatory response.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Testosterona / Medicamentos Herbarios Chinos / Ratas Sprague-Dawley Límite: Animals / Humans / Male Idioma: En Revista: J Tradit Chin Med Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Testosterona / Medicamentos Herbarios Chinos / Ratas Sprague-Dawley Límite: Animals / Humans / Male Idioma: En Revista: J Tradit Chin Med Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China